United States · Funded startup

Who invested in AxoGen

10 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

HealthcareMedical Devices

Raised 9 months ago

Funding summaryUpdated 26 Oct 2026

$198Mraised across 10 rounds since 2007, from 10 sources

$12MSeries C$2.6MDebt$3.4MVenture$3.7MDebt$3.0MDebt$1.0MVenture$18MSeries A$13MRound$18MRound$124MRound
Latest round
Round, $124MJan 2026
Led by
Mizuho Capital and Wells Fargo Securities
Step-upi
7.1×
Investors
8 (2 led)
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2007201020132016201920222025
$12MSeries C$2.6MDebt$3.4MVenture$3.0MDebt$1.0MVenture$18MSeries A$13MRound$18MRound$124MRound
First round
Series C, $12M
Dec 2007
Biggest round
$124M
Round · Jan 2026
Usual gap between rounds
12 months
the median of 9

The rounds

  1. Jan 2026
  2. Aug 2015
    Round$18M

    No investor was named in the report.

    From a historical funding record

  3. Feb 2015
    Round$13M

    No investor was named in the report.

    From a historical funding record

  4. Aug 2013
    Series A$18M

    No investor was named in the report.

    Reported by fiercemedicaldevices.com

  5. Oct 2011
    Venture$1.0M

    No investor was named in the report.

    Reported by sec.govSEC filing: $1.0M sold, first sale Sept 2011

  6. Jun 2011
    Debt$3.0M

    No investor was named in the report.

    Reported by sec.govSEC filing: $3.0M sold, first sale May 2011

  7. Jan 2011
    Debt$3.7M

    No investor was named in the report.

    Reported by sec.govSEC filing: $3.7M sold, first sale Jun 2010

  8. Jan 2010
    Venture$3.4M

    No investor was named in the report.

    Reported by sec.govSEC filing: $3.4M sold, first sale Jan 2010

  9. Jun 2009
    Debt$2.6M

    No investor was named in the report.

    From a historical funding recordSEC filing: $2.6M sold, first sale Sept 2009

  10. Dec 2007

Founders and team

From the SEC filings it signed: 6 on the team.

  • Brad P. HedgerExecutive Officeri
  • David P. HansenExecutive Officeri
  • Gregory G. FreitagExecutive Officer, Directori
  • John P. EngelsExecutive Officeri
  • Karen ZaderejExecutive Officer, Directori
  • Mark P. FriedmanExecutive Officeri

On the board, as filediJamie M. GroomsJoe M. MandatoJohn M. HarperMark M. GoldRobert J. Rudelius

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Mizuho CapitalVC firm1round, led 1
Wells Fargo SecuritiesVC firm1round, led 1
De Novo VenturesGrowth equity1round
Cardinal PartnersInvestment bank1round
Springboard CapitalInvestment firm1round
Canaccord GenuityInvestment firm1round
Raymond JamesAngel1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about AxoGen

Who invested in AxoGen?

AxoGen's investors include Mizuho Capital, Wells Fargo Securities, De Novo Ventures, Accuitive Medical Ventures and Cardinal Partners, and 3 more on record. Mizuho Capital led its latest round.

How much has AxoGen raised?

AxoGen has raised $198M across 10 rounds since 2007.

When did AxoGen last raise?

AxoGen's most recent round was an Undisclosed round of $124M in Jan 2026, led by Mizuho Capital.

What was AxoGen's biggest round?

Its most recent round, $124M in Jan 2026, is also its largest on record.

Who backed AxoGen first?

AxoGen's first round on record, in Dec 2007, was backed by De Novo Ventures, Accuitive Medical Ventures and Cardinal Partners and 1 others.

What stage is AxoGen at?

AxoGen's latest named round is an Undisclosed round, in Jan 2026.

Where is AxoGen based?

AxoGen is based in the United States.

Who led AxoGen's rounds?

Mizuho Capital led the Undisclosed round in 2026.

Companies like AxoGen

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.